From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Genentech · AbbVie (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
899
total citations
- FWCI
- 41.38
- Percentile
- 100%
- References
- 105
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Venetoclax
- Bcl-2 family
- MCL1
- Apoptosis
- Cancer research
- Cancer
- Myeloid
- Programmed cell death
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.